Clinical Trials Info:

Rosacea Clinical Studies

Exploring gastrointestinal bacterial colonization in rosacea as a biomarker for systemic abnormalities in innate immunity

Enrollment status: Open

Rosacea is a common chronic inflammatory skin disease that affects 2-3% of the population in the United States. The exact cause of rosacea remains unclear, but many contributing factors have been established. For this study, we will seek to learn if an abnormal amount of bacterial colonization of the gastrointestinal (GI) tract leads to an abnormality in the body's natural and automatic defense system and contributes to the development of rosacea. The relationship between gastrointestinal (GI) bacteria and rosacea has been proposed in the past, but this study will serve to validate that claim. We will compare the gastrointestinal bacterial colonization in subjects with rosacea and those without rosacea using a standard breath testing and stool analysis methods. Blood testing will be performed to profile immune responses correlating with colonization.

Study coordinator: Nicole Nechiporchik, (734) 232-0562 or dermtrials@med.umich.edu
Please reference Derm #: 682